Evaluation of the effectiveness of foetal fibronectin as a predictor of preterm birth in symptomatic preterm labour women
- PMID: 31296172
- PMCID: PMC6625081
- DOI: 10.1186/s12884-019-2403-7
Evaluation of the effectiveness of foetal fibronectin as a predictor of preterm birth in symptomatic preterm labour women
Abstract
Background: The prediction of preterm birth (PTB) is important in the management of symptomatic preterm labour women. We evaluated the effectiveness of the foetal fibronectin (fFN) test for predicting PTB in symptomatic preterm labour women with consideration of physiologic changes in cervical length (CL) during pregnancy.
Methods: This prospective study included 85 women with symptomatic preterm labour of a singleton pregnancy. Positive fFN was defined as a fFN level of > 50 ng/mL in cervicovaginal secretion, while a short CL was defined as that below 25th percentile at the corresponding gestational age. We evaluated effectiveness of the fFN test, CL, and the combination of these two tests, including sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV), positive likelihood ratio (LR+), negative likelihood ratio (LR-) to predict the PTB within 7 and 14 days of testing and PTB at < 34 and 37 weeks of gestation. We also present the odds ratios (ORs) of the test results, defining the women with both negative results as the reference group.
Results: Of the 85 women, 31 (36.5%) showed a positive fFN and 44 (51.8%) had a short CL. PTB occurred within 7 and 14 days of testing and before 34 and 37 weeks of gestation in 17.6, 20.0, 23.5 and 49.4% of the women, respectively. The fFN and CL results showed low predictive effectiveness for the studied outcomes with LR+ (fFN, 1.5-1.9; CL, 1.0-1.5) and LR- (fFN, 0.7; CL, 0.7-0.9). The combined use of fFN and CL could not improve these results (LR+, 1.4-2.3; LR-, 0.7-0.9). However, the risk of PTB before 37 weeks was increased in women with positive fFN but not CL shortening compared to the reference group (odds ratio [OR], 3.8; 95% confidence interval [CI], 1.1-1.3). The risk of PTB before 34 weeks was increased in both positive fFN and CL compared to the reference group (OR, 8.1; 95% CI, 1.9-34.5).
Conclusion: Although, our approach could not improve the ability to predict PTB, it could identify women at risk for delivery before 34 or 37 weeks of gestation. Therefore, it could be used to manage women with symptomatic preterm labour.
Keywords: Cervical length; Foetal fibronectin; Preterm birth.
Conflict of interest statement
The authors declare that they have no competing interests.
Similar articles
-
Predictive performance of PAMG-1 vs fFN test for risk of spontaneous preterm birth in symptomatic women attending an emergency obstetric unit: retrospective cohort study.Ultrasound Obstet Gynecol. 2018 May;51(5):644-649. doi: 10.1002/uog.18892. Epub 2018 Mar 26. Ultrasound Obstet Gynecol. 2018. PMID: 28850753
-
Accuracy of fetal fibronectin for the prediction of preterm birth in symptomatic twin pregnancies: a pilot study.Sci Rep. 2018 Feb 1;8(1):2160. doi: 10.1038/s41598-018-20447-5. Sci Rep. 2018. PMID: 29391455 Free PMC article.
-
Quantitative fetal fibronectin and cervical length in symptomatic women: results from a prospective blinded cohort study.J Matern Fetal Neonatal Med. 2019 Nov;32(22):3792-3800. doi: 10.1080/14767058.2018.1472227. Epub 2018 May 15. J Matern Fetal Neonatal Med. 2019. PMID: 29727248 Free PMC article.
-
Prediction of preterm delivery in symptomatic women using PAMG-1, fetal fibronectin and phIGFBP-1 tests: systematic review and meta-analysis.Ultrasound Obstet Gynecol. 2018 Oct;52(4):442-451. doi: 10.1002/uog.19119. Epub 2018 Sep 4. Ultrasound Obstet Gynecol. 2018. PMID: 29920825
-
Three biomarker tests to help diagnose preterm labour: a systematic review and economic evaluation.Health Technol Assess. 2019 Mar;23(13):1-226. doi: 10.3310/hta23130. Health Technol Assess. 2019. PMID: 30917097 Free PMC article.
Cited by
-
Physical Examination-Indicated Cerclage in Singleton and Twin Pregnancies and Risk Factors for Predicting Preterm Birth < 28 Weeks.J Pers Med. 2023 Dec 28;14(1):38. doi: 10.3390/jpm14010038. J Pers Med. 2023. PMID: 38248739 Free PMC article.
-
Fetal Fibronectin as a Predictor of Preterm Delivery: A Nigerian Cohort Study.Biomed Res Int. 2022 Sep 15;2022:2442338. doi: 10.1155/2022/2442338. eCollection 2022. Biomed Res Int. 2022. PMID: 36158889 Free PMC article.
-
Current and Emerging Strategies for Prediction and Diagnosis of Prelabour Rupture of the Membranes: A Narrative Review.Malays J Med Sci. 2021 Jun;28(3):5-17. doi: 10.21315/mjms2021.28.3.2. Epub 2021 Jun 30. Malays J Med Sci. 2021. PMID: 34285641 Free PMC article. Review.
-
Predicting Spontaneous Preterm Birth Using the Immunome.Clin Perinatol. 2024 Jun;51(2):441-459. doi: 10.1016/j.clp.2024.02.013. Epub 2024 Apr 4. Clin Perinatol. 2024. PMID: 38705651 Free PMC article. Review.
-
Vaginal host immune-microbiome-metabolite interactions associated with spontaneous preterm birth in a predominantly white cohort.NPJ Biofilms Microbiomes. 2025 Mar 26;11(1):52. doi: 10.1038/s41522-025-00671-4. NPJ Biofilms Microbiomes. 2025. PMID: 40140683 Free PMC article.
References
-
- Blencowe H, Cousens S, Oestergaard MZ, Chou D, Moller AB, Narwai R, et al. National, regional, and worldwide estimates of preterm birth rates in the year 2010 with time trends since 1990 for selected countries: a systematic analysis and implications. Lancet. 2012;379:2162–2172. doi: 10.1016/S0140-6736(12)60820-4. - DOI - PubMed
-
- Roberts D, Dalziel S. Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth. Cochrane Database Syst Rev. 2006;19:Cd004454. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical